Looking for more insight i guess that illustrates how this animal study by Dr. Minn, requested by the FDA, will be different from animal studies already cunducted by the company's CFO, and why. Maybe the model of the upcoming preclinical is a test run of sorts. Perhaps a short lived process involving the newly assembled team and lab locations. Like most have said, and i believe, the science hasn't changed. However, entering human trials, the design and model of the study most likely has. My guess, this is a step precluding human trial design and will not take to long. dare i say alongside phase I trials?

Still long here.